StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Grifols, S.A.
MCE:GRF.MC
Sector
Location
Market Cap
USD 7.70 B
Share Price
USD 14.33
Avg Daily Volume
2,018,562
Change (1 day)
2.41%
Change (1 year)
43.99%
Change (YTD)
51.23%
Grifols, S.A. Accounts Payable for the year ending December 31, 2024: USD 882.55 M
Grifols, S.A. Accounts Payable is USD 882.55 M for the year ending December 31, 2024, a -1.66% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Grifols, S.A. Accounts Payable for the year ending December 31, 2023 was USD 897.47 M, a 14.60% change year over year.
-
Grifols, S.A. Accounts Payable for the year ending December 31, 2022 was USD 783.11 M, a 9.37% change year over year.
-
Grifols, S.A. Accounts Payable for the year ending December 31, 2021 was USD 716.01 M, a -2.57% change year over year.
-
Grifols, S.A. Accounts Payable for the year ending December 31, 2020 was USD 734.92 M, a 12.54% change year over year.
Competitors
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.05
1.99%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.71
002653.SZ
-0.29
-4.12%
Globus Medical, Inc.
USD 53.29
GMED
-0.75
-1.39%
Regencell Bioscience Holdings Limited
USD 15.18
RGC
+0.39
2.64%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.83
600566.SS
-0.03
-0.72%
Apeloa Pharmaceutical Co.,Ltd
USD 2.21
000739.SZ
+0.06
3.02%
Jubilant Pharmova Limited
USD 13.53
JUBLPHARMA.NS
-0.05
-0.40%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.57
600420.SS
+0.02
1.34%
NovoCure Limited
USD 12.54
NVCR
-3.97
-24.05%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.58
300026.SZ
+0.02
3.80%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.68
603567.SS
+0.10
6.47%
Raffles Medical Group Ltd
USD 0.81
BSL.SI
+0.01
0.92%
Evotec SE
USD 8.00
EVT.DE
+0.51
6.87%
Nipro Corporation
USD 9.36
8086.T
+0.06
0.67%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.05
1.99%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.71
002653.SZ
-0.29
-4.12%
Globus Medical, Inc.
USD 53.29
GMED
-0.75
-1.39%
Regencell Bioscience Holdings Limited
USD 15.18
RGC
+0.39
2.64%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.83
600566.SS
-0.03
-0.72%
Apeloa Pharmaceutical Co.,Ltd
USD 2.21
000739.SZ
+0.06
3.02%
Jubilant Pharmova Limited
USD 13.53
JUBLPHARMA.NS
-0.05
-0.40%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.57
600420.SS
+0.02
1.34%
NovoCure Limited
USD 12.54
NVCR
-3.97
-24.05%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.58
300026.SZ
+0.02
3.80%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.68
603567.SS
+0.10
6.47%
Raffles Medical Group Ltd
USD 0.81
BSL.SI
+0.01
0.92%
Evotec SE
USD 8.00
EVT.DE
+0.51
6.87%
Nipro Corporation
USD 9.36
8086.T
+0.06
0.67%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%